Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2010
07/01/2010US20100163852 Material for light-emitting device and light-emitting device
06/2010
06/30/2010EP2202230A1 Competitive inhibitors of type ii dehydroquinase enzyme
06/30/2010EP2202222A2 Indene derivatives, their preparation and use as medicaments
06/30/2010EP2200994A1 Condensed compounds with activity at estrogen receptors
06/30/2010EP1960379B1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010EP1558572B1 Novel compounds and their use as prar-modulators
06/30/2010EP1380556B1 Compound for organic el element and organic el element
06/30/2010CN101765585A antibacterial agents
06/30/2010CN101759604A Guanidyl substitutional tetracycline derivative
06/30/2010CN101759599A Tetracycline compound with amino isonitroso
06/30/2010CN101759598A Tetracycline compound with amino acid amidine
06/29/2010US7745483 2-Halofuryl-thienyl-3-carboxamides
06/29/2010US7745482 crystal structured distrontium salt of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, used in the prevention and treatment of osteoporosis and osteoarthritis
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745456 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp.
06/29/2010US7744889 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
06/29/2010CA2442881C New process for the industrial synthesis of the tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis ofbivalent salts of ranelic acid and their hydrates
06/29/2010CA2306409C Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
06/24/2010WO2010070910A1 1-heterodiene derivative and harmful organism control agent
06/24/2010WO2010069457A1 Anthra[2,3-b]benzo[d]thiophene derivatives and their use as organic semiconductors
06/24/2010WO2010036027A3 Novel compound, method for preparing same and organic electronic device using same
06/24/2010US20100160632 Bisamid-zinkbasen
06/24/2010US20100160423 Small molecule antagonists of bacterial quorum-sensing receptors
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160337 Sulfamides as trpm8 modulators
06/24/2010US20100160327 Modified Malonate Derivatives
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/24/2010US20100160166 Inhibitors of a 9-cis epoxycarotenoid dioxygenase
06/24/2010US20100158996 Ester compound and medical use thereof
06/24/2010US20100158798 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity
06/24/2010CA2747424A1 1-heterodiene derivative and harmful organism control agent
06/23/2010EP2197871A1 Metallocene compounds based on ethanediyl-bridged indene and cyclopentadithiophene ligands
06/23/2010EP2197869A1 Sulphonium salt initiators
06/23/2010EP2197839A1 Sulphonium salt initiators
06/23/2010EP2197835A1 Bicyclic aryl and heteroaryl receptor modulators
06/23/2010EP2197271A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
06/23/2010CN201512489U Device for producing sulfolene
06/23/2010CN201512488U Cyclobutyl sulfone device for manufacturing cyclobutyl sulfone
06/23/2010CN201512487U Device for producing sulfolane
06/23/2010CN101754947A Process for preparation of sulfamide derivatives
06/23/2010CN101747317A Method for enriching thianaphthene from mixtures containing thianaphthene and naphthalene
06/23/2010CN101747316A High-purity strontium ranelate and preparation method thereof
06/23/2010CN101747292A Benzoylguanidine-trimetazidine conjugate, as well as preparation method and medical application thereof
06/23/2010CN101157682B Method for preparing acetyl thiophene
06/23/2010CA2647900A1 Inhibitors of a 9-cis-epoxycarotenoid dioxygenase
06/22/2010US7741362 4-amino-(S)-2-N-(4-methyl-1-naphthalenesulfonyl)amino-N'-(1,2,3,4-tetrahydro-1-naphthyl)butanamide, arylsulfonylamino based peptidomimetics used for imaging tissues and/or organs such as brain, blood vessels or tumors; medical diagnosis
06/22/2010US7741359 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
06/17/2010WO2010067442A1 Method for producing alcohol compound
06/17/2010WO2010066755A1 Process for the preparation of (6s)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (rotigotine)
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2196454A2 Exo-and diastereo-selective syntheses of himbacine analogs
06/16/2010EP2195656A2 Human t2r bitterness receptors and uses thereof
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase
06/16/2010CN1867528B Compounds based on fluoranthene and use thereof
06/16/2010CN1837194B Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones compound
06/16/2010CN101743223A Novel compounds as cannabinoid receptor ligands
06/16/2010CN101048403B Heterocyclic antiviral compounds
06/15/2010US7737303 Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
06/15/2010US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients
06/15/2010US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared
06/15/2010US7737140 Therapeutic compounds
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/10/2010WO2010064871A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/10/2010WO2010064605A1 Method for manufacturing sulfolene compound and method for manufacturing sulfolane compound
06/10/2010WO2010063802A1 3, 4-di-substituted cyclobutene- 1, 2 -diones as cxcr2 receptor antagonists
06/10/2010WO2010063773A1 Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/10/2010US20100145075 Process for the preparation of chymase modulators
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145047 Inhibitors of diacylglycerol acyltransferase
06/10/2010US20100144785 Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/10/2010US20100144681 Compounds for the treatment of alzheimer's disease
06/10/2010US20100143404 Thiophene derivatives for up-regulating HLA-DM activity
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/10/2010CA2742703A1 Novel 4- (heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/09/2010EP2193117A1 Inhibitors of beta amyloid production
06/09/2010EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
06/09/2010CN1882533B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
06/09/2010CN101730688A 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
06/09/2010CN101723940A Bithiophene compound and pharmaceutical composite and application thereof
06/09/2010CN101723931A Method for synthesizing 4-thio-bicyclo [3.1.0]-2-hexene-6-formic ether
06/09/2010CN101723930A Shikimic acid compound and preparation method and application thereof
06/09/2010CN101721412A Methods of treating microbial infections in humans and animals
06/09/2010CN101326653B Organic semiconductor device and organic semiconductor thin film
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732483 DNA-PK inhibitors
06/08/2010US7732466 5-chloro-thiophene-2-carboxylic acid-N-{1-[3-chloro-4-(pyrrolidin-1-yl-carbonyl)-phenylcarbamoly]-ethyl}-amide, having antithrombotic activity and blood-coagulation factor Xa inhibiting activity
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 329